International Isotopes Inc. reported revenue from the sale of product of $3.3 million for the third quarter of 2025, a decrease of 16% compared to the same period in the previous year. For the nine months ended September 30, 2025, revenue from the sale of product was $10.2 million, an increase of 2% from the prior year. The company reported a net loss of $203,600 for the third quarter, compared to a net profit of $150,300 in the same period last year. For the first nine months of 2025, net loss was $477,100, an increase from a net loss of $237,200 in the same period last year. Non-GAAP EBITDA for the first nine months of 2025 was $15,000. In the Fluorine Products segment, there were no sales, and the company incurred $26,100 and $82,300 in expenses for the three and nine months ended September 30, 2025, respectively. The company received $30,000 and $60,000 in extension payments related to the Fluorine Products Asset Sale during the same periods and is awaiting regulatory consent to complete the asset sale, expected by March 2026.